We also observed no differences in the percentages of TNFR2+ CCR2+ classical monocytes, non-classical monocytes, intermediate monocytes, or TNFR2+ CCR2+ neutrophils between healthy controls and ischemic stroke patients (Figure 4c and Table 4). This evidence concerns the gene CCR2 and ischemic stroke.